Back to Search Start Over

Prognostic impact of <scp> KMT2A‐AFF1 </scp> ‐positivity in 926 <scp> BCR‐ABL1 </scp> ‐negative B‐lineage acute lymphoblastic leukemia patients treated in <scp>GIMEMA</scp> clinical trials since 1996